Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
    • All Access
      • Learn More
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » A Hereditary, Childhood Form of Parkinsonism

    A Hereditary, Childhood Form of Parkinsonism

    February 1, 2011
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    DaTSCAN to Distinguish Parkinson’s Disease from Secondary Parkinsonism

    Long-term Impact of Medulloblastoma Treatment in Childhood

    Keywords

    Neurology

    A Hereditary, Childhood Form of Parkinsonism

    Abstract and Commentary

    By Sabiha Merchant, MD, and Steven Weinstein, MD. Dr. Merchant is Attending Pediatric Neurology; Director, Pediatric Epilepsy Fellowship, New York Presbyterian Hospital. Dr. Weinstein is Director of the Pediatric Comprehensive Epilepsy Program, Weill Cornell Medical College. Neither Dr. Merchant and Dr. Weinstein report any financial relationships relevant to this field of study.

    Synopsis: Dopamine transporter deficiency (DAT) is a rare inherited disorder that causes a Parkinsonian syndrome in infants and young children.

    Source: Kurian MA, Li Y, Zhen J, et al. Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: An observational cohort and experimental study. Lancet Neurol 2011;10:54-62.

    Parkinsonian disorders typically present in adults but rare forms exist in early infancy. A multitude of etiologies exist and this paper describes a cohort of children with a deficiency of the dopamine transporter (DAT) due to mutations of SLC6A3. The identification of the molecular basis of this disorder has the potential to lead to specific therapeutic strategies and perhaps allelic variations to provide insight into adult onset disorders.

    An international multicenter study was performed to characterize the clinical and molecular characteristics in 11 children with hereditary dopamine transporter deficiency syndrome (DAT). Patients were identified from seven pediatric neurology centers, movement disorder and neurotransmitter specialists, laboratories performing CSF neurotransmitter analysis, and a review of published cases in PubMed.

    Patients presented between 0.5 and 7 months of age with Parkinsonism, hyperkinesia, or a combination. Video movies of the children created by the parents and the clinics were reviewed independently by three neurologists. The history was reviewed to identify any risk for intrauterine and perinatal injury (cerebral palsy), and, although the results were not provided, an evaluation was performed to exclude a metabolic basis for the neurological findings—assessment for a mitochondrial disorder, MRI search for iron accumulation, and measurement of CSF neurotransmitters to exclude a biosynthesis defect. An elevated ratio of homovanillic acid to 5-hydroxyindoleactic was suggestive of DAT and prompted further genetic evaluation for SLC6A3 mutations.

    The clinical phenotype was an early infancy presentation with irritability, feeding difficulty, and movement disorders. All children had generalized dystonia within one year of clinical presentation. As the disease progressed, axial hypotonia and pyramidal tract features became more obvious. By age 3 years, all had pyramidal tract findings and severe gross motor delay. Basal ganglia, as visualized on MRI, had no gross structural defects or signal abnormalities. GI motor deficits, sleeping difficulties, pneumonias, and orthopedic complications developed. Features of DAT were almost indistinguishable from patients who had defects of dopamine biosynthesis, but may be suggested by the high incidence of dystonic crises in DAT. Cognitive impairment was mild and speech delays were thought to be due primarily to the motor difficulties. Death occurred in 4 of 5 children who survived to age 9 due to respiratory complications and cardiac failure.

    Evaluation of CSF neurotransmitters was the most sensitive indicator of the disorder that prompted genetic analysis. An elevated homovanillic acid to 5-hydroxyindoleactic ratio distinguished DAT from synthesis defects in which both levels were low. Mutations in the autosomal recessive gene SLC6A3 were found in each case leading to defective trafficking of dopamine reuptake into the presynaptic neuron resulting in cerebral dopamine deficiency. It is postulated that dopamine accumulates extraneuronally, resulting in dopamine degradation. Serotonin biosynthetic pathways were unaffected.

    Therapeutic interventions that had little of no efficacy, including muscle relaxants, dopamine agonists, anticholinergics, antiglutaminergics, GABA agents, and deep brain stimulation in one child. Partial response to carbidopa was seen in two patients with residual DAT activity.

    Commentary

    The paper emphasizes that many of childhood movement disorders require an extensive evaluation both to identify systemic metabolic disorders and disorders of dopamine synthesis, transport, and metabolism. Correct identification may allow for more accurate prediction of the time course of a progressive disorder. The authors did not discuss whether acquired enzymatic deficits may develop in adults in response to environmental factors. We do not know what effect the aging process has on this enzyme system.

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Neurology Alert

    View PDF
    Neurology Alert 2011-02-01
    February 1, 2011

    Table Of Contents

    Vascular Endothelial Growth Factor and Neuropathy

    The ABCs of Anosognosia for Hemiplegia

    Sleep Disorders and Restless Legs Syndrome in Friedreich's Ataxia

    Gait Ataxia in Essential Tremor Modulated by Thalamic Deep Brain Stimulation

    A Hereditary, Childhood Form of Parkinsonism

    Stroke Alert: A Review of Current Clinical Stroke Literature

    Clinical Briefs in Primary Care Supplement

    Pharmacology Watch

    Begin Test
    Buy this Issue/Course

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events

    Free Email Newsletters

    All Fields Required

    E-Newsletter Options
    • Accreditation Council for Continuing Medical Education
    • American Nurses Credentialing Center
    • American College of Emergency Physician
    • American Board of Internal Medicine: Maintenance of Certification
    • California Board of Registered Nursing
    • Commission for Case Manager Certification
    • American Academy of Pediatrics
    • American Osteopathic Association
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
    • All Access
      • Learn More
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2019 Relias. All rights reserved.

    Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing